SCHEMBL14581925

SCHEMBL14581925

CCOCC1CCN(S(=O)(=O)Nc2cccc(CC)n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.41
IKBKB O14920 1/20 0.35
CHUK O15111 1/20 0.35
JAK1 P23458 1/20 0.35
CCR6 P51684 1/20 0.35
GAA P10253 2/20 0.35
TSHR P16473 1/20 0.35
CTPS1 P17812 1/20 0.34
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
ATM Q13315 1/20 0.33
MAPK1 P28482 2/20 0.32
ALOX15 P16050 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TP53 P04637 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474721 0.90 HSD11B1 (0.39) HSD11B1IKBKBCHUKJAK1CCR6
SCHEMBL5469272 0.86 HSD11B1 (0.39) HSD11B1IKBKBCHUKJAK1CCR6
SCHEMBL5473934 0.85 HSD11B1 (0.36) HSD11B1KMT2A
SCHEMBL5473662 0.85 HSD11B1 (0.41) HSD11B1CTPS1CHRNB2CHRNB4CHRNA3
SCHEMBL14581922 0.84 PKM (0.42) GAATSHRATMMEN1KMT2A
SCHEMBL5481988 0.83 HSD11B1 (0.43) HSD11B1TSHRATMMEN1KMT2A
SCHEMBL5468447 0.82 ALDH1A1 (0.50) GAATSHRMAPK1MEN1KMT2A
SCHEMBL5471141 0.81 CARM1 (0.42) HSD11B1ALDH1A1HPGD
SCHEMBL5471502 0.80 HSD11B1 (0.41) HSD11B1IKBKBCHUKCCR6GAA
SCHEMBL14581935 0.80 GRIN1 (0.43) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives HSD11B1, HSD11B2, HSD17B11 HSD11B1 1/4885IKBKB 436/4885CHUK 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.